BIOSECURE Nudges Celltrion’s Jump Into CDMO Business

New Drug Development, Other plans

 
• By Jung Won Shin
  
Celltrion Group Chairman Jungjin Seo
CDMO Subsidiary May Begin To Generate Sales From 2028
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Business